Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Annual Review of Medicine|September 4, 2020
Autoimmune Endocrinopathies: An Emerging Complication of Immune Checkpoint InhibitorsZoe Quandt, Arabella Young, Ana Luisa Perdigoto, et al.Cancer Research|July 26, 2015
A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1Shin Foong Ngiow, Arabella Young, Nicolas Jacquelot, et al.The Oncologist|June 19, 2023
Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint InhibitorsJordyn Silverstein, Francis Wright, Michelle Wang, et al.Oncoimmunology|May 6, 2015
Co-blockade of immune checkpoints and adenosine A<sub>2A</sub> receptor suppresses metastasisArabella Young, Deepak Mittal, Kimberley Stannard, et al.Plos One|August 4, 2012
Depletion of c-Rel from cytokine gene promoters is required for chromatin reassembly and termination of gene responses to T cell activationFiona S Poke, William R Upcher, Owen R Sprod, et al.Cancer Research|July 3, 2014
Antimetastatic effects of blocking PD-1 and the adenosine A2A receptorDeepak Mittal, Arabella Young, Kimberley Stannard, et al.The Oncologist|February 8, 2024
Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical TrialsMuhammad Zaki Hidayatullah Fadlullah, Ching-Nung Lin, Samuel Coleman, et al.Science Immunology|October 3, 2020
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasisJames C Lee, Sadaf Mehdizadeh, Jennifer Smith, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 4, 2025
Polymer-based chemo-immunotherapy: Combining immunogenic cell death induction and PD-L1 blockade enhances antitumor immunity in melanomaJiahui Li, Hasan Al Faruque, Emilio Cortes-Sanchez, et al.BMC Cancer|November 6, 2014
RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitizationArabella Young, Rachael Berry, Adele F Holloway, et al.Pageof 5